Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Aarti Drugs Limited ( (IN:AARTIDRUGS) ).
Aarti Drugs Limited has announced that its officials will participate in an investor conference organized by Investec on March 11, 2026, at Trident BKC in Mumbai, holding one-on-one and group meetings with analysts and institutional investors. The company emphasized that discussions will be restricted to publicly available information, with no unpublished price-sensitive information to be shared, underscoring its adherence to regulatory norms and transparency in investor communications.
More about Aarti Drugs Limited
Aarti Drugs Limited is an Indian pharmaceutical company engaged in manufacturing active pharmaceutical ingredients, intermediates, and formulations. The company primarily serves domestic and international markets in the healthcare sector, supplying key drug ingredients to generic and branded medicine makers.
Average Trading Volume: 7,141
Technical Sentiment Signal: Sell
Current Market Cap: 32.63B INR
For detailed information about AARTIDRUGS stock, go to TipRanks’ Stock Analysis page.